Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
Objectives: This study was aimed to investigate the efficacy and safety of vortioxetine hydrobromide in the treatment of major depressive disorder (MDD). Methods: One hundred and eighty patients with the newly diagnosed depression in our hospital between August 2018 and August 2019 were selected and...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Professional Medical Publications
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |